• USP7–PKM2 Axis Regulates Macrophage Metabolism in Pancreatit

  2026-07-09

  This study uncovers how ubiquitin-specific protease 7 (USP7) controls macrophage polarization in severe acute pancreatitis (SAP) through metabolic reprogramming via pyruvate kinase M2 (PKM2). These findings provide mechanistic insight into inflammatory regulation and highlight PKM2 as a potential therapeutic target for SAP.

• TAI-1 Hec1 Inhibitor: Applied Workflows for Cancer Research

  2026-07-09

  TAI-1 offers unprecedented precision in targeting mitotic regulation via Hec1 inhibition, transforming experimental and translational cancer workflows. This guide details protocol optimizations, troubleshooting strategies, and context-specific use-cases that maximize TAI-1’s impact across diverse tumor models.

• Carrier-Free Triterpene Prodrug Enables Targeted OSCC Therap

  2026-07-08

  This study pioneers a carrier-free, self-assembled prodrug strategy using natural triterpenes for targeted oral squamous cell carcinoma (OSCC) chemotherapy. The approach leverages ROS-responsive linkers and dual compound synergy to achieve selective, efficient drug delivery and release, representing a significant advance in chemotherapeutic design.

• JSH-23: Advanced NF-κB Inhibitor Workflows for Inflammation

  2026-07-08

  JSH-23 distinguishes itself as a precise NF-κB inhibitor, enabling researchers to dissect inflammatory signaling with robust specificity. This article details optimized workflows, troubleshooting strategies, and comparative insights to maximize the reproducibility and translational relevance of JSH-23-driven experiments.

• Hyperthermia and Cisplatin Cooperate via Caspase-8 to Drive

  2026-07-07

  This study uncovers how combining hyperthermia with cisplatin treatment enhances cancer cell death by promoting caspase-8 accumulation, K63-linked polyubiquitination, and activation. These findings provide mechanistic insight into the synergy between physical and chemical therapies in inducing both apoptosis and pyroptosis, suggesting new avenues for precision oncology.

• S1P/S1PR3 Axis Drives Neuronal Apoptosis After ICH via TNF-α

  2026-07-07

  This study elucidates how sphingosine-1-phosphate (S1P) activation of S1PR3 intensifies neuronal apoptosis after acute intracerebral hemorrhage (ICH) by triggering the TNF-α/caspase-3 signaling cascade. These findings clarify a crucial pathological mechanism and establish S1PR3 as a promising therapeutic target for mitigating neuroinflammatory injury following ICH.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-07-06

  This study uncovers how selective autophagy, mediated by CALCOCO2/NDP52, modulates the stability of the transcription factor IRF3 to maintain a balanced type I interferon (IFN) response. The discovery of PSMD14/POH1's deubiquitinating activity as a regulatory checkpoint offers new insights into the crosstalk between autophagy and innate immune signaling, suggesting refined strategies for manipulating transcription factor regulation in antiviral and immunological research.

• Thiazovivin (A5506) ROCK Inhibitor for Stem Cell Protocols

  2026-07-06

  Thiazovivin is a high-purity ROCK inhibitor designed to enhance induced pluripotent stem cell generation and improve human embryonic stem cell survival during workflows that involve single-cell dissociation and reprogramming. It is best suited for research protocols in stem cell biology and is not intended for diagnostic or therapeutic use.

• EZ Cap EGFP mRNA 5-moUTP: Advancing Fluorescent mRNA Deliver

  2026-07-05

  EZ Cap™ EGFP mRNA (5-moUTP) empowers reliable, immune-silent delivery of enhanced green fluorescent protein mRNA in both in vitro and in vivo settings. Its advanced Cap 1 structure, 5-moUTP modifications, and long poly(A) tail set a new standard for robust translation and sustained reporter expression.

• Spatially Patterned Kidney Assembloids Advance Disease Model

  2026-07-04

  Huang et al. present a spatially organized human kidney assembloid model that recapitulates nephron self-assembly and functional architecture, addressing key limitations of conventional kidney organoids. Their approach enables high-fidelity modeling of complex kidney diseases and offers a robust platform for regenerative medicine research.

• Discovery of PAS: A PRC2 Subunit Essential for Subtelomeric

  2026-07-03

  McNaught et al. identified PAS, a previously uncharacterized accessory subunit of the Polycomb repressive complex 2 (PRC2), as crucial for subtelomeric H3K27 methylation and gene repression in Neurospora crassa. This work clarifies the modular composition of fungal PRC2 and has broad implications for understanding chromatin regulation mechanisms.

• Serotonin Inhibits HRP-Based Biotinylation: Mechanisms and S

  2026-07-03

  This study uncovers a previously unrecognized inhibitory effect of serotonin on horseradish peroxidase (HRP)-mediated protein biotinylation, a cornerstone technique for proximity labeling in neuroscience. The authors identify a chemical strategy to reverse this inhibition, improving the fidelity of subsynaptic proteomic profiling in serotonergic systems.

• Trichostatin A (TSA): Translating Epigenetic Insights Into O

  2026-07-02

  Explore how Trichostatin A (TSA), a potent HDAC inhibitor, is reshaping translational cancer research by unlocking epigenetic mechanisms for cell cycle control, tumor differentiation, and combination therapies. This article bridges mechanistic insight with actionable strategies for oncology investigators, leveraging recent breakthroughs and APExBIO’s gold-standard reagent.

• Multianimal MRI Accelerates Tumor Assessment in KPC Mouse Mo

  2026-07-02

  Kempinska et al. introduce a multianimal MRI protocol enabling simultaneous, high-resolution imaging of pancreatic tumors in genetically engineered mouse models. This approach increases throughput and consistency for evaluating tumor growth and chemotherapy response, supporting more efficient preclinical research.

• Multianimal MRI Accelerates Pancreatic Tumor Evaluation in K

  2026-07-01

  Kempinska et al. present a validated multianimal MRI protocol enabling simultaneous, high-resolution tumor measurement in genetically engineered KPC mouse models of pancreatic cancer. This workflow substantially increases throughput and cost-effectiveness for preclinical studies, including the assessment of chemotherapeutic response with agents such as Gemcitabine HCl.

453 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page